An SEC filing shows the supplier issuing equity to win the customer’s commitment — a reversal of the usual direction of value in AI infrastructure deals.
The warrant described below is unvested and unexercised on the face of the filing — Anthropic does not own Akamai stock, and the underlying preferred shares are non-voting. No percentage of Akamai appears below, and that is deliberate: the 8-K gives share counts rather than a denominator, so no ownership percentage is computed here. The $11.6 billion is subject to termination rights and delivery conditions, which makes it a ceiling rather than a booked amount. The per-common strike and the $9.0 billion implied by the later tranches are this publication’s arithmetic on disclosed terms.
What Happened
Akamai Technologies filed a Form 8-K with the SEC on 24 September 2026 — earliest event date 18 September — disclosing that it entered two instruments, Project Plan 2 and Project Plan 3, with Anthropic, PBC under a Master Services Agreement dated 5 May 2026. The aggregate value across both plans is described as “approximately $11.6 billion,” each carrying an “initial seven-year term commencing on their respective service start dates.” Those start dates are not given in the filing.
Alongside the commercial agreement, Akamai issued Anthropic a warrant for 387,051 Series B Non-Voting Convertible Preferred Shares, each “initially convertible into 20 shares of Common Stock,” for up to 7,741,020 shares on an as-converted basis. Two facts must be stated precisely before going further: the warrant is unvested and unexercised on the face of the filing, and the preferred shares are non-voting. Anthropic holds a contingent right to purchase — not Akamai stock.
This piece declines to compute an ownership percentage of Akamai. The filing supplies share counts; it does not supply a denominator. Any percentage derived from those counts alone would be arithmetically incomplete, and none appears below.
The vesting schedule is where the filing stops being a press release and starts being informative, so it is worth taking in order. Nothing vests on execution. The warrant exists at contract close and is, at that moment, entirely unvested.
A first tranche of 40 per cent vests “upon the first payment by Anthropic or its subsidiaries or affiliates… under Project Plan 3”. The trigger is cash movement rather than contract execution — the grant begins to vest when Anthropic starts paying, not when either party signs. The three remaining tranches, 20 per cent each, vest “upon each additional $3.0 billion of contractual value committed by Anthropic”.
Three tranches at $3.0 billion apiece means the unvested 60 per cent corresponds to $9.0 billion of further commitment before the warrant vests in full. That is this publication’s own arithmetic on the vesting terms, not a figure either party disclosed. What the structure amounts to is an earn-in indexed to volume: the customer does not pay the issuer for shares, it earns the right to buy them by committing more spend.
The strike is set at a trailing market average. The filing gives “$2,226.60 per Warrant Share, representing the volume-weighted average price of the Company’s common stock… over the 30 consecutive trading days immediately preceding the Issue Date, multiplied by 20”. Divided by that same twenty-to-one conversion ratio, the figure is $111.33 per common share — a division that is ours rather than a disclosed number. The consequence is worth stating plainly: struck at a trailing thirty-day average, the warrant is not issued in the money, carries no built-in discount, and its value is contingent rather than cash. No value is assigned to it here.
The key insight: Nothing vests on signature. The 40% first tranche unlocks when cash moves under Project Plan 3, and the remaining 60% — implying $9.0B of further commitment by this publication’s arithmetic on the disclosed terms — vests in three equal tranches tied to volume, not time. This is an earn-in indexed to spend, not a share grant.

The Structural Read
In most AI infrastructure deals, value flows from the customer toward the supplier — a buyer taking a stake in the vendor it depends on, or a hyperscaler pre-purchasing capacity ahead of its own demand. The equity moves in the direction of future optionality, and the party with money uses that money to secure access to the party with capability.
Here the direction is reversed. The supplier issued the warrant; the customer received it. That inversion is the structural signal worth reading carefully.
Inference from Instrument Shape
“A vendor that grants equity to win a commitment is signaling that the commitment is the scarce object — not the capacity. Capacity can be built and financed. Contracted demand to fill it is the thing that had to be bought, and it was bought partly in stock.”
That is an inference from the shape of the instrument and nothing more. It is not a claim about either party’s negotiating position, and this piece does not characterize either company as weak or strong. What the instrument’s architecture does reveal is a cost structure: the equity component is a customer acquisition cost, deferred and conditional, paid in optionality rather than cash.
The exercise price — struck at a trailing 30-day volume-weighted average with no discount — means the warrant carries no built-in economic transfer at issuance. Its value is entirely contingent on future stock performance and on Anthropic actually exercising. Nothing here values the instrument; doing so would require assumptions the filing does not support.
Placed against the Map of AI framework, this deal sits at the infrastructure layer — compute and delivery capacity — where margins compress as competition scales and where securing long-duration, contracted demand has become the genuine constraint. The filing’s architecture is consistent with that reading: the scarcer resource in the deal is not the servers but the customer commitment to fill them.
Three Implications
IMPLICATION 1 — THE COMMITMENT IS THE PRODUCT
At the infrastructure layer of the AI stack, building capacity is financeable. What is not easily financeable is certainty about who uses it. A seven-year, multi-billion-dollar contract — even one subject to termination rights — converts demand uncertainty into a plannable asset. The warrant is the price Akamai paid to convert that uncertainty. The calculus the instrument exposes is a plain one, and it is the question any supplier at this layer is already answering whether or not it writes the answer into a filing: how much equity is a long-duration committed customer worth?
IMPLICATION 2 — $11.6B IS A CEILING, NOT A BOOKING
The filing is explicit: the aggregate is “subject to termination rights” and to delivery and service-availability conditions. Anthropic may terminate on material uncured breach or on a change of control in favor of a direct competitor. Either party may terminate on bankruptcy or if no project plan remains in effect. The change-of-control provision is notable — the customer has contractually secured the right to exit if the supplier is acquired by a rival. No acquirer is named or implied here, and no likelihood is attached to any termination. The narrow read: seven years running from undisclosed service start dates, with bilateral exits built in, is the upper bound of the relationship, not its floor.
IMPLICATION 3 — VESTING AS A VOLUME DISCLOSURE MECHANISM
The vesting schedule also ties a piece of Akamai’s capital structure to a number nobody outside the contract can see. Committed contractual value is not a disclosed line item; the tranches are defined against it. So the vesting terms establish a correspondence between an unobservable quantity and an observable instrument — which is an observation about how the terms are written, not a claim that any particular filing follows, or when. This piece does not assert what either party is required to disclose about vesting, because the 8-K does not address it — not by design necessarily, but as a consequence of SEC reporting rules applied to an equity-linked, volume-gated earn-in.
The Bottom Line
The $11.6 billion figure is a ceiling on a conditional relationship, not a booked revenue line — subject to termination rights, tied to undisclosed service start dates, and structured so that the bulk of it earns Anthropic an equity option rather than transferring cash to Akamai shareholders. What the filing actually discloses is a structural argument: at the AI infrastructure layer in 2026, committed demand is scarce enough that a supplier will pay for it in stock, deferred, contingent, and indexed to the volume it is trying to secure. The warrant’s vesting schedule is the most honest price list in the document.
Sources: Akamai Technologies Form 8-K, SEC EDGAR, 24 September 2026. Structural analysis and arithmetic on vesting tranches and implied per-share exercise price are this publication’s own, derived from disclosed terms.
91,000+ executives read Business Engineer for the AI strategy frameworks cited by ChatGPT, Claude, and Perplexity.
The warrant described above is unvested and unexercised on the face of the filing. Anthropic does not own Akamai stock, and the underlying Series B Preferred Shares are non-voting — what it holds is a contingent right to acquire, not a shareholding. No percentage of Akamai appears above, and that is deliberate: the 8-K discloses share counts rather than a denominator, so this publication declines to compute an ownership percentage on any basis. The approximately $11.6 billion is subject to termination rights and to delivery and service-availability conditions, which makes it the top of a range rather than a booked amount, and the seven-year terms run from service start dates the filing does not provide. The $111.33 per common share and the $9.0 billion of further commitment implied by the three later tranches are this publication’s own arithmetic on disclosed terms, not figures anyone announced. The warrant is struck at a trailing thirty-day volume-weighted average, so it is not issued in the money, and no value is assigned to it above. The reading that the direction of the equity indicates which side of the transaction is scarce is an inference from the shape of the instrument. It is not a fact about either party’s negotiating position, and nothing above describes either company as weak or strong. No possible acquirer is named in connection with the change-of-control provision, nothing above suggests any acquisition is contemplated, and no likelihood is attached to any termination. Whether any tranche has vested, whether any payment has been made, the service start dates, Akamai’s share count, and any revenue, capex or guidance figure are not established and do not appear — a limit of this reporting rather than evidence that none exist. Nothing above predicts Akamai, Anthropic, the stock, whether any tranche vests, or whether any expansion occurs.









